Fusen Pharmaceutical Company Limited (HKG:1652)

Hong Kong · Delayed Price · Currency is HKD

0.9300

+0.0400 (4.49%)

At close: Feb 13, 2026

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Shuanghuanglian Oral Solutions	159.02M
Shuanghuanglian Oral Solutions Growth	-47.82%
Shuanghuanglian Injections	84.92M
Shuanghuanglian Injections Growth	-21.57%
Nicardipine Hydrochloride Injections	24.30M
Nicardipine Hydrochloride Injections Growth	-19.43%
Heat-clearing and Detoxicating Oral Solutions	12.90M
Heat-clearing and Detoxicating Oral Solutions Growth	-75.99%
Other	72.35M
Other Growth	-35.15%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	353.49M
China Growth	-43.44%